BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28709866)

  • 1. Mesenchymal stem cell transplantation carried in SVVYGLR modified self-assembling peptide promoted cardiac repair and angiogenesis after myocardial infarction.
    Gao XR; Xu HJ; Wang LF; Liu CB; Yu F
    Biochem Biophys Res Commun; 2017 Sep; 491(1):112-118. PubMed ID: 28709866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.
    Cai H; Wu FY; Wang QL; Xu P; Mou FF; Shao SJ; Luo ZR; Zhu J; Xuan SS; Lu R; Guo HD
    FASEB J; 2019 Jul; 33(7):8306-8320. PubMed ID: 30970221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.
    Lu F; Zhao X; Wu J; Cui Y; Mao Y; Chen K; Yuan Y; Gong D; Xu Z; Huang S
    Int J Cardiol; 2013 Sep; 167(6):2524-32. PubMed ID: 22981278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
    Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
    J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts.
    Zhang D; Huang W; Dai B; Zhao T; Ashraf A; Millard RW; Ashraf M; Wang Y
    Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1339-47. PubMed ID: 20802132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats.
    Ishikane S; Hosoda H; Yamahara K; Akitake Y; Kyoungsook J; Mishima K; Iwasaki K; Fujiwara M; Miyazato M; Kangawa K; Ikeda T
    Transplantation; 2013 Oct; 96(8):697-706. PubMed ID: 23912174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome improvement of cellular cardiomyoplasty using triple therapy: mesenchymal stem cell+erythropoietin+vascular endothelial growth factor.
    Tavakoli F; Ostad SN; Khori V; Alizadeh AM; Sadeghpour A; Darbandi Azar A; Haghjoo M; Zare A; Nayebpour M
    Eur J Pharmacol; 2013 Aug; 714(1-3):456-63. PubMed ID: 23850947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
    Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J
    Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
    Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Xu ZQ; Zhang FM; Cao KJ; Ma WZ
    Gene Ther; 2006 Nov; 13(22):1564-8. PubMed ID: 16810195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
    Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining erythropoietin infusion with intramyocardial delivery of bone marrow cells is more effective for cardiac repair.
    Zhang D; Zhang F; Zhang Y; Gao X; Li C; Yang N; Cao K
    Transpl Int; 2007 Feb; 20(2):174-83. PubMed ID: 17239026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells cardiac patch from decellularized umbilical artery improved heart function after myocardium infarction.
    Li N; Huang R; Zhang X; Xin Y; Li J; Huang Y; Cui W; Stoltz JF; Zhou Y; Kong Q
    Biomed Mater Eng; 2017; 28(s1):S87-S94. PubMed ID: 28372282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of marrow-derived cardiac stem cells carried in designer self-assembling peptide nanofibers improves cardiac function after myocardial infarction.
    Guo HD; Cui GH; Wang HJ; Tan YZ
    Biochem Biophys Res Commun; 2010 Aug; 399(1):42-8. PubMed ID: 20637726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
    Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
    Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cell treatment with PDGF-BB and reperfusion on cardiac persistence of mononuclear and mesenchymal bone marrow cells after transplantation into acute myocardial infarction in rats.
    Krausgrill B; Vantler M; Burst V; Raths M; Halbach M; Frank K; Schynkowski S; Schenk K; Hescheler J; Rosenkranz S; Müller-Ehmsen J
    Cell Transplant; 2009; 18(8):847-53. PubMed ID: 19520046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained delivery of VEGF from designer self-assembling peptides improves cardiac function after myocardial infarction.
    Guo HD; Cui GH; Yang JJ; Wang C; Zhu J; Zhang LS; Jiang J; Shao SJ
    Biochem Biophys Res Commun; 2012 Jul; 424(1):105-11. PubMed ID: 22732415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of hRAMP1 modified mesenchymal stem cells on restenosis and heart function in rabbit model of carotid angioplasty and myocardial infarction].
    Long XP; Zhao RZ; Shi B; Xu GX; Chen CY
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(30):2134-9. PubMed ID: 23158279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.